Financials data is unavailable for this security.
View more
Year on year The Biotech Growth Trust PLC 's revenues fell -- from 79.73m to -77.53m. has gone from a gain of 74.60m to a loss of 82.66m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -25.91% |
|---|---|
| Return on equity | -28.38% |
| Return on investment | -28.38% |
More ▼
Cash flow in GBPView more
In 2025, The Biotech Growth Trust PLC increased its cash reserves by 296.67%, or 6.32m. Cash Flow from Investing totalled 115.85m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 5.09m for operations while cash used for financing totalled 104.29m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 8.16 |
|---|---|
| Tangible book value per share | 8.16 |
More ▼
Balance sheet in GBPView more
| Current ratio | 1.56 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in GBP
Year on year, growth in earnings per share excluding extraordinary items dropped -226.72%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -226.69 |
